Drug comparisons
Fremanezumab vs Zavegepant
Fremanezumab (Ajovy) vs Zavegepant (Zavzpret): CGRP migraine comparison. Monthly prevention injection vs nasal acute treatment. Efficacy, safety, and uses.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when evaluating CGRP pathway drugs for migraine management, specifically distinguishing between preventive and acute therapies.
Bottom line
Neither drug is inherently better; Fremanezumab excels in prevention and Zavegepant in acute treatment, so they address different aspects of migraine care.
All medication comparisons